<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36008456</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Airway epithelial immunoproteasome subunit LMP7 protects against rhinovirus infection.</ArticleTitle><Pagination><StartPage>14507</StartPage><MedlinePgn>14507</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">14507</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-18807-3</ELocationID><Abstract><AbstractText>Immunoproteasomes (IP) serve as an important modulator of immune responses to pathogens and other pathological factors. LMP7/&#x3b2;5i, one of the IP subunits, plays a critical role in autoimmune diseases by downregulating inflammation. Rhinovirus (RV) infection is a major risk factor in the exacerbations of respiratory inflammatory diseases, but whether LMP7 regulates RV-mediated inflammation in the lung particularly in the airway epithelium, the first line of defense against RV infection, remains unclear. In this study, we determined whether airway epithelial LMP7 promotes the resolution of RV-mediated lung inflammation. Inducible airway epithelial-specific LMP7-deficient (conditional knockout, CKO) mice were generated to reveal the in vivo anti-inflammatory and antiviral functions of LMP7. By using LMP7-deficient primary human airway epithelial cells generated by CRISPR-Cas9, we confirmed that airway epithelial LMP7 decreased pro-inflammatory cytokines and viral load during RV infection. Additionally, airway epithelial LMP7 enhanced the expression of a negative immune regulator A20/TNFAIP3 during viral infection that may contribute to the anti-inflammatory function of LMP7. We also discovered that induction of LMP7 by a low dose of polyinosinic:polycytidylic acid (PI:C) reduced RV-mediated inflammation in our CKO mice infected with RV. Our findings suggest that airway epithelial LMP7 has anti-inflammatory and antiviral functions that is critical to the resolution of RV-mediated lung inflammation. Induction of airway epithelial LMP7 may open a novel avenue for therapeutic intervention against RV infection.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dimasuay</LastName><ForeName>Kris Genelyn</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, USA. dimasuayg@njhealth.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaunaman</LastName><ForeName>Niccolette</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berg</LastName><ForeName>Bruce</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cervantes</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute for Medicine Biochemistry and Molecular Biology, Universit&#xe4;tsmedizin Greifswald, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heppner</LastName><ForeName>Frank L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Corporate Member of Freie Universit&#xe4;t Berlin and Humboldt-Universit&#xe4;t zu Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrington</LastName><ForeName>Deborah A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Doheny Eye Institute, University of California Los Angeles, Pasadena, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Hong Wei</ForeName><Initials>HW</Initials><AffiliationInfo><Affiliation>Department of Medicine, National Jewish Health, Denver, CO, USA. chuh@njhealth.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI150082</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AI150082</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36008456</ArticleId><ArticleId IdType="pmc">PMC9403975</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-18807-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-18807-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ferrington DA, Gregerson DS. Immunoproteasomes: Structure, function, and antigen presentation. Prog. Mol. Biol. Transl. Sci. 2012;109:75&#x2013;112. doi: 10.1016/B978-0-12-397863-9.00003-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-397863-9.00003-1</ArticleId><ArticleId IdType="pmc">PMC4405001</ArticleId><ArticleId IdType="pubmed">22727420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kammerl IE, et al. Impairment of immunoproteasome function by cigarette smoke and in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2016;193:1230&#x2013;1241. doi: 10.1164/rccm.201506-1122OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201506-1122OC</ArticleId><ArticleId IdType="pubmed">26756824</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy MK, et al. Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection. Virology. 2016;498:57&#x2013;68. doi: 10.1016/j.virol.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5045817</ArticleId><ArticleId IdType="pubmed">27560373</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzke CC, Ebstein F, Kallinich T. Role of proteasomes in inflammation. J. Clin. Med. 2021 doi: 10.3390/jcm10081783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081783</ArticleId><ArticleId IdType="pmc">PMC8072576</ArticleId><ArticleId IdType="pubmed">33923887</ArticleId></ArticleIdList></Reference><Reference><Citation>Mundt S, Basler M, Buerger S, Engler H, Groettrup M. Inhibiting the immunoproteasome exacerbates the pathogenesis of systemic Candida albicans infection in mice. Sci. Rep. 2016;6:19434. doi: 10.1038/srep19434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep19434</ArticleId><ArticleId IdType="pmc">PMC4726078</ArticleId><ArticleId IdType="pubmed">26776888</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu L, et al. Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection. Eur. J. Immunol. 2009;39:3385&#x2013;3394. doi: 10.1002/eji.200839117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200839117</ArticleId><ArticleId IdType="pubmed">19830724</ArticleId></ArticleIdList></Reference><Reference><Citation>Robek MD, Garcia ML, Boyd BS, Chisari FV. Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus. J. Virol. 2007;81:483&#x2013;491. doi: 10.1128/JVI.01779-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-06</ArticleId><ArticleId IdType="pmc">PMC1797445</ArticleId><ArticleId IdType="pubmed">17079320</ArticleId></ArticleIdList></Reference><Reference><Citation>Opitz E, et al. Impairment of immunoproteasome function by beta5i/LMP7 subunit deficiency results in severe enterovirus myocarditis. PLoS Pathog. 2011;7:e1002233. doi: 10.1371/journal.ppat.1002233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002233</ArticleId><ArticleId IdType="pmc">PMC3164653</ArticleId><ArticleId IdType="pubmed">21909276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimasuay KG, et al. Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways. Clin. Sci. (Lond.) 2018;132:1711&#x2013;1723. doi: 10.1042/CS20180337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180337</ArticleId><ArticleId IdType="pmc">PMC7105891</ArticleId><ArticleId IdType="pubmed">29980604</ArticleId></ArticleIdList></Reference><Reference><Citation>Heink S, Ludwig D, Kloetzel PM, Kruger E. IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response. Proc. Natl. Acad. Sci. U. S. A. 2005;102:9241&#x2013;9246. doi: 10.1073/pnas.0501711102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0501711102</ArticleId><ArticleId IdType="pmc">PMC1166598</ArticleId><ArticleId IdType="pubmed">15944226</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin TA, et al. Immunoproteasome assembly: Cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 1998;187:97&#x2013;104. doi: 10.1084/jem.187.1.97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.187.1.97</ArticleId><ArticleId IdType="pmc">PMC2199179</ArticleId><ArticleId IdType="pubmed">9419215</ArticleId></ArticleIdList></Reference><Reference><Citation>De M, et al. Beta 2 subunit propeptides influence cooperative proteasome assembly. J. Biol. Chem. 2003;278:6153&#x2013;6159. doi: 10.1074/jbc.M209292200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209292200</ArticleId><ArticleId IdType="pubmed">12456675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura H, Caturegli P, Takahashi M, Suzuki K. New insights into the function of the immunoproteasome in immune and nonimmune cells. J. Immunol. Res. 2015;2015:541984. doi: 10.1155/2015/541984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/541984</ArticleId><ArticleId IdType="pmc">PMC4617869</ArticleId><ArticleId IdType="pubmed">26636107</ArticleId></ArticleIdList></Reference><Reference><Citation>Arima K, et al. Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo&#x2013;Nishimura syndrome. Proc. Natl. Acad. Sci. U. S. A. 2011;108:14914&#x2013;14919. doi: 10.1073/pnas.1106015108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1106015108</ArticleId><ArticleId IdType="pmc">PMC3169106</ArticleId><ArticleId IdType="pubmed">21852578</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehm A, et al. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production. J. Clin. Investig. 2015;125:4196&#x2013;4211. doi: 10.1172/JCI81260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81260</ArticleId><ArticleId IdType="pmc">PMC4639987</ArticleId><ArticleId IdType="pubmed">26524591</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasutomo K. Dysregulation of immunoproteasomes in autoinflammatory syndromes. Int. Immunol. 2019;31:631&#x2013;637. doi: 10.1093/intimm/dxy059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxy059</ArticleId><ArticleId IdType="pubmed">30169676</ArticleId></ArticleIdList></Reference><Reference><Citation>Seifert U, et al. Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress. Cell. 2010;142:613&#x2013;624. doi: 10.1016/j.cell.2010.07.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.07.036</ArticleId><ArticleId IdType="pubmed">20723761</ArticleId></ArticleIdList></Reference><Reference><Citation>de Freitas Chama LL, et al. Immunoproteasome impairment via beta5i/LMP7-deletion leads to sustained pancreatic injury from experimental pancreatitis. J. Cell Mol. Med. 2021;25:6786&#x2013;6799. doi: 10.1111/jcmm.16682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16682</ArticleId><ArticleId IdType="pmc">PMC8278072</ArticleId><ArticleId IdType="pubmed">34132031</ArticleId></ArticleIdList></Reference><Reference><Citation>Beale J, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci. Transl. Med. 2014;6:256ra134. doi: 10.1126/scitranslmed.3009124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009124</ArticleId><ArticleId IdType="pmc">PMC4246061</ArticleId><ArticleId IdType="pubmed">25273095</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller IE, et al. Regulation of immunoproteasome function in the lung. Sci. Rep. 2015;5:10230. doi: 10.1038/srep10230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10230</ArticleId><ArticleId IdType="pmc">PMC4437306</ArticleId><ArticleId IdType="pubmed">25989070</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Anti-viral immune response in the lung and thymus: Molecular characterization and expression analysis of immunoproteasome subunits LMP2, LMP7 and MECL-1 in pigs. Biochem. Biophys. Res. Commun. 2018;502:472&#x2013;478. doi: 10.1016/j.bbrc.2018.05.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.05.190</ArticleId><ArticleId IdType="pubmed">29856997</ArticleId></ArticleIdList></Reference><Reference><Citation>Momtazi G, Lambrecht BN, Naranjo JR, Schock BC. Regulators of A20 (TNFAIP3): New drug-able targets in inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2019;316:L456&#x2013;L469. doi: 10.1152/ajplung.00335.2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00335.2018</ArticleId><ArticleId IdType="pubmed">30543305</ArticleId></ArticleIdList></Reference><Reference><Citation>Tompkins DH, et al. Sox2 activates cell proliferation and differentiation in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 2011;45:101&#x2013;110. doi: 10.1165/rcmb.2010-0149OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2010-0149OC</ArticleId><ArticleId IdType="pmc">PMC3145063</ArticleId><ArticleId IdType="pubmed">20855650</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins KA, Bavari S, Salazar AM. Vaccine adjuvant uses of poly-IC and derivatives. Expert Rev. Vaccines. 2015;14:447&#x2013;459. doi: 10.1586/14760584.2015.966085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14760584.2015.966085</ArticleId><ArticleId IdType="pubmed">25308798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumaki Y, Salazar AM, Wandersee MK, Barnard DL. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol((R)) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model. Antiviral Res. 2017;139:1&#x2013;12. doi: 10.1016/j.antiviral.2016.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.12.007</ArticleId><ArticleId IdType="pmc">PMC7113886</ArticleId><ArticleId IdType="pubmed">27956136</ArticleId></ArticleIdList></Reference><Reference><Citation>Maelfait J, et al. A20 deficiency in lung epithelial cells protects against influenza A virus infection. PLoS Pathog. 2016;12:e1005410. doi: 10.1371/journal.ppat.1005410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005410</ArticleId><ArticleId IdType="pmc">PMC4731390</ArticleId><ArticleId IdType="pubmed">26815999</ArticleId></ArticleIdList></Reference><Reference><Citation>Shembade N, Harhaj E. A20 inhibition of NFkappaB and inflammation: Targeting E2:E3 ubiquitin enzyme complexes. Cell Cycle. 2010;9:2481&#x2013;2482. doi: 10.4161/cc.9.13.12269.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.13.12269</ArticleId><ArticleId IdType="pmc">PMC3052412</ArticleId><ArticleId IdType="pubmed">20543575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiemstra PS, McCray PB, Jr, Bals R. The innate immune function of airway epithelial cells in inflammatory lung disease. Eur. Respir. J. 2015;45:1150&#x2013;1162. doi: 10.1183/09031936.00141514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00141514</ArticleId><ArticleId IdType="pmc">PMC4719567</ArticleId><ArticleId IdType="pubmed">25700381</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker D, Prince A. Innate immunity in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 2011;45:189&#x2013;201. doi: 10.1165/rcmb.2011-0011RT.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2011-0011RT</ArticleId><ArticleId IdType="pmc">PMC3175551</ArticleId><ArticleId IdType="pubmed">21330463</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo JR, Peters SP, Busse WW. Asthma exacerbations: Pathogenesis, prevention, and treatment. J. Allergy Clin. Immunol. Pract. 2017;5:918&#x2013;927. doi: 10.1016/j.jaip.2017.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2017.05.001</ArticleId><ArticleId IdType="pmc">PMC5950727</ArticleId><ArticleId IdType="pubmed">28689842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganjian H, Rajput C, Elzoheiry M, Sajjan U. Rhinovirus and innate immune function of airway epithelium. Front. Cell Infect. Microbiol. 2020;10:277. doi: 10.3389/fcimb.2020.00277.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00277</ArticleId><ArticleId IdType="pmc">PMC7316886</ArticleId><ArticleId IdType="pubmed">32637363</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Niewiesk S. Synergistic induction of interferon alpha through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats. Vaccine. 2014;32:265&#x2013;270. doi: 10.1016/j.vaccine.2013.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.11.013</ArticleId><ArticleId IdType="pmc">PMC4283819</ArticleId><ArticleId IdType="pubmed">24262312</ArticleId></ArticleIdList></Reference><Reference><Citation>Flur K, et al. Viral RNA induces type I interferon-dependent cytokine release and cell death in mesangial cells via melanoma-differentiation-associated gene-5: Implications for viral infection-associated glomerulonephritis. Am. J. Pathol. 2009;175:2014&#x2013;2022. doi: 10.2353/ajpath.2009.080585.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2009.080585</ArticleId><ArticleId IdType="pmc">PMC2774065</ArticleId><ArticleId IdType="pubmed">19850889</ArticleId></ArticleIdList></Reference><Reference><Citation>French T, et al. The immunoproteasome subunits LMP2, LMP7 and MECL-1 are crucial along the induction of cerebral toxoplasmosis. Front. Immunol. 2021;12:619465. doi: 10.3389/fimmu.2021.619465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.619465</ArticleId><ArticleId IdType="pmc">PMC8099150</ArticleId><ArticleId IdType="pubmed">33968021</ArticleId></ArticleIdList></Reference><Reference><Citation>Verhelst K, van Loo G, Beyaert R. A20: Attractive without showing cleavage. EMBO Rep. 2014;15:734&#x2013;735. doi: 10.15252/embr.201439014.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201439014</ArticleId><ArticleId IdType="pmc">PMC4196973</ArticleId><ArticleId IdType="pubmed">24878850</ArticleId></ArticleIdList></Reference><Reference><Citation>Coornaert B, et al. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 2008;9:263&#x2013;271. doi: 10.1038/ni1561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1561</ArticleId><ArticleId IdType="pubmed">18223652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lappas M. A20, an essential component of the ubiquitin-editing protein complex, is a negative regulator of inflammation in human myometrium and foetal membranes. Mol. Hum. Reprod. 2017;23:628&#x2013;645. doi: 10.1093/molehr/gax041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molehr/gax041</ArticleId><ArticleId IdType="pubmed">28911210</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartlett NW, et al. Defining critical roles for NF-kappaB p65 and type I interferon in innate immunity to rhinovirus. EMBO Mol. Med. 2012;4:1244&#x2013;1260. doi: 10.1002/emmm.201201650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201201650</ArticleId><ArticleId IdType="pmc">PMC3531601</ArticleId><ArticleId IdType="pubmed">23165884</ArticleId></ArticleIdList></Reference><Reference><Citation>Basler M, Groettrup M. On the role of the immunoproteasome in protein homeostasis. Cells. 2021 doi: 10.3390/cells10113216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113216</ArticleId><ArticleId IdType="pmc">PMC8621243</ArticleId><ArticleId IdType="pubmed">34831438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Park NY, Jang Y, Ma A, Jiang Q. Vitamin E gamma-tocotrienol inhibits cytokine-stimulated NF-kappaB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids. J. Immunol. 2015;195:126&#x2013;133. doi: 10.4049/jimmunol.1403149.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1403149</ArticleId><ArticleId IdType="pmc">PMC4475472</ArticleId><ArticleId IdType="pubmed">26002975</ArticleId></ArticleIdList></Reference><Reference><Citation>Denlinger LC, et al. Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation. Am. J. Respir. Crit. Care Med. 2011;184:1007&#x2013;1014. doi: 10.1164/rccm.201103-0585OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201103-0585OC</ArticleId><ArticleId IdType="pmc">PMC3208645</ArticleId><ArticleId IdType="pubmed">21816938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy JL, et al. Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am. J. Respir. Crit. Care Med. 2014;189:532&#x2013;539. doi: 10.1164/rccm.201310-1767OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201310-1767OC</ArticleId><ArticleId IdType="pmc">PMC3977713</ArticleId><ArticleId IdType="pubmed">24471509</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto M, Seya T. TLR3: Interferon induction by double-stranded RNA including poly(I:C) Adv. Drug Deliv. Rev. 2008;60:805&#x2013;812. doi: 10.1016/j.addr.2007.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2007.11.005</ArticleId><ArticleId IdType="pubmed">18262679</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapp S, et al. Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G. J. Virol. 2009;83:884&#x2013;895. doi: 10.1128/JVI.00023-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00023-08</ArticleId><ArticleId IdType="pmc">PMC2612396</ArticleId><ArticleId IdType="pubmed">19004943</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakhama A, Chu HW. The use of CRISPR-Cas9 technology to reveal important aspects of human airway biology. Methods Mol. Biol. 2018;1799:371&#x2013;380. doi: 10.1007/978-1-4939-7896-0_27.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7896-0_27</ArticleId><ArticleId IdType="pubmed">29956165</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimasuay KG, et al. Parkin, an E3 ubiquitin ligase, enhances airway mitochondrial DNA release and inflammation. Thorax. 2020;75:717&#x2013;724. doi: 10.1136/thoraxjnl-2019-214158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2019-214158</ArticleId><ArticleId IdType="pubmed">32499407</ArticleId></ArticleIdList></Reference><Reference><Citation>Southam DS, Dolovich M, O&#x2019;Byrne PM, Inman MD. Distribution of intranasal instillations in mice: Effects of volume, time, body position, and anesthesia. Am. J. Physiol. Lung Cell Mol. Physiol. 2002;282:L833&#x2013;839. doi: 10.1152/ajplung.00173.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00173.2001</ArticleId><ArticleId IdType="pubmed">11880310</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyles JE, Spiers ID, Williamson ED, Alpar HO. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine. 1998;16:2000&#x2013;2009. doi: 10.1016/s0264-410x(98)00089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0264-410x(98)00089-9</ArticleId><ArticleId IdType="pubmed">9796057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>